|Articles|November 1, 1997

New and Emerging Therapies in the Treatment of Type 2 Diabetes
Volume 3
Issue 10 Suppl

Declaring War on Diabetes: New Strategies for Old Battles

Author(s)Joel Zonszein, MD

Download PDF: Declaring War on Diabetes: New Strategies for Old Battles

Articles in this issue

over 28 years ago

Article

Goals and Objectives

over 28 years ago

Article

Participating Faculty

over 28 years ago

Article

Diabetes: New Insights, Innovative Approaches

over 28 years ago

Article

Roundtable Discussions - Diabetes Prevalence, Development and Progression

over 28 years ago

Article

Roundtable Discussions - Diabetes Management Techniques

over 28 years ago

Article

Selected Abstracts

over 28 years ago

Article

CME Quiz

over 28 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

The Timing and Characteristics of Supplemental Indications for Medicines

ByYingying Zhu, PhD,Claire H. Brennan, BA,Haijun Tian, PhD,Josephine N. Tran, PharmD, MS,Peter J. Neumann, ScD,James D. Chambers, PhD,Pei-Jung Lin, PhD,Meng Li, PhD

July 6th 2026

State Medicaid Budgetary Implications of New Cancers

ByAmanda C. Chen, PhD,Anuraag R. Kansal, PhD,David C. Grabowski, PhD

July 2nd 2026

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

ByKaitlyn T. Haas, PharmD,Joseph J. Saseen, PharmD, BCPS, BCACP,Oliver Titus, MS,Nathan Lamberton, PharmD, BCACP,Lisa M. Schilling, MD, MSPH,Keri N. Hogan, PharmD, BCACP,Alison Marks, BA,Sarah J. Billups, PharmD, BCPS

Declaring War on Diabetes: New Strategies for Old Battles

Articles in this issue

Related Content

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

The Timing and Characteristics of Supplemental Indications for Medicines

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

Trending on AJMC

340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs

FDA Approves Atacicept for IgA Nephropathy

Ebola Cases Top 1700 as Unpaid Health Workers Strike

Quest Adds Haystack MRD to OncoEMR for Community Oncology

IL-6, Not hsCRP, Modified Lp(a)-Associated CAD Risk

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Declaring War on Diabetes: New Strategies for Old Battles

Articles in this issue

Related Content

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

The Timing and Characteristics of Supplemental Indications for Medicines

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

Trending on AJMC

340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs

FDA Approves Atacicept for IgA Nephropathy

Ebola Cases Top 1700 as Unpaid Health Workers Strike

Quest Adds Haystack MRD to OncoEMR for Community Oncology

IL-6, Not hsCRP, Modified Lp(a)-Associated CAD Risk